Lonza · 17 hours ago
QC Associate I Microbiology
Lonza is a global leader in life sciences operating across five continents. They are seeking a QC Associate I (Microbiology) to perform a variety of tests in support of GMP operations, including sampling and analyses, while participating in continuous improvement initiatives.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Perform testing of routine and non-routine samples and documents according to GMP
Review data and assess against established acceptance criteria, identify discrepancies. Provide input to design of quality investigations and CAPA initiatives as needed
Perform routine lab maintenance; order and maintain lab supply inventory
Receive and provide training
Coordinate with customers to support operational activities, identify and support resolution of technical problems
Consistently meeting production schedules, actively participate in group and project teamwork; project and process improvements
Adhere to GMP policies and procedures, including documentation activities
Qualification
Required
B.S./B.A degree in Life Science or related field
Experience is in pharmaceutical or biopharmaceutical industry desirable
Knowledge of assays/laboratory functions; prepare basic and complex reagents as assigned
Experience working in a GMP environment
Benefits
Performance-related bonus
Medical, dental and vision insurance
401(k) matching plan
Life insurance, as well as short-term and long-term disability insurance
Employee assistance programs
Paid Time Off
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Recent News
NH Business Review
2026-01-17
Company data provided by crunchbase